Abstract Glucagon-like peptide-1 (GLP-1) is a gut-derived hormone essential for maintaining glucose homeostasis through multiple physiological pathways: triggering insulin release, inhibiting glucagon secretion, delaying gastric emptying, enhancing feelings of fullness, and suppressing appetite
Wegovy, also known as semaglutide, will now be available to thousands of obese individuals in England through the NHS
Side effects in the trial were mostly gastrointestinal nausea, diarrhoea, vomiting, constipation and most were rated mild to moderate
To adapt comfortably, start with a smaller serving and slowly increase it
This marks a significant milestone in the diabetes treatment landscape as it introduces a more affordable option for patients managing type 2 diabetes
It includes consults, meds, supplies, and shipping, but no coaching or lifestyle support